Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, discusses the importance of accurate imaging and bone marrow assessment in managing solitary plasmacytomas, highlighting the need for proper follow-up and the role of radiotherapy as a first-line treatment option. Dr Zamagni emphasizes the significance of implementing good imaging techniques to prevent major errors in diagnosis and treatment. This interview took place at the 23rd International Myeloma Society (IMS) Annual Meeting in Glasgow, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.